Source: Annual Congress 2002 - Steroid and other anti-inflammatory agents
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. S. Postma, N. Schlösser, C. Sevette, Y. Martinat, J. Aumann, H. Kafé (Groningen, Heidelberglaan, The Netherlands; Perpignan, Lyon, St-Quentin, France; Hasselt, Belgium). Morning and evening administration of inhaled ciclesonide is equally effective in treatment of asthma. Eur Respir J 2002; 20: Suppl. 38, 1913

Member's Comments

No comment yet.

Related content which might interest you: Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening Source: Eur Respir J 2001; 17: 1083-1088 Year: 2001 Indacaterol once-daily is equally effective dosed either in the evening or morning in COPD patients Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009 Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006 Once daily ciclesonide and twice daily fluticasone propionate are equally effective in the treatment of patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 Budesonide and formoterol in a single inhaler is more effective than a higher dose of inhaled corticosteroid in mild-moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Once daily ciclesonide delivered via pMDI is effective and safe for the treatment of mild-to-moderate persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 208s Year: 2006 The efficacy of inhaled fluticasone furoate (FF) and vilanterol (VI) administered in combination in asthma is comparable when administered in the morning or evening Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Budesonide and formoterol in a single inhaler is safe and effective in the treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Once-daily, high-dose inhaled fluticasone propionate and salmeterol in patients having moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 125s Year: 2004 Low-dose single-inhaler budesonide/formoterol administered once daily is effective in mild-persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 158s Year: 2001 Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Short-acting bronchodilator and oral steroid use in asthma patients prescribed either concurrent beclometasone and salmeterol or combined salmeterol/fluticasone Source: Eur Respir J 2004; 24: Suppl. 48, 309s Year: 2004 Effectiveness and safety of fluticasone propionate/salmeterol 250/50mcg administered once daily to patients with persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 309s Year: 2004 Efficacy of low dose theophylline and inhaled corticosteroids in smokers with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Is low dose inhaled fluticasone propionate safe in young children with asthma? Source: Annual Congress 2008 - Preschool wheezing: advances in diagnosis, phenotyping and therapy Year: 2008 Dosage tapering of inhalatory budesonide in subjects with mild-moerate persistent asthma treated with montelukast Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003 Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001 Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma Source: Eur Respir J 2009; 33: 1277-1286 Year: 2009 24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids}, Source: Eur Respir J 2012; 40: 570-579 Year: 2012